RETHINK ADHD ADULTS
DEAD

Serial Number

86384407

Owner

H. Lundbeck A/S

Attorney

Claudia A. Smith

Filing Date

Sep 3, 2014

Add to watchlist:

No watchlists yet
View on USPTO

RETHINK ADHD ADULTS Trademark

Serial Number: 86384407

RETHINK ADHD ADULTS is a trademark filed by H. Lundbeck A/S on September 3, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

September 3, 2014

Registration Date

Not Registered

Published for Opposition

May 19, 2015

Goods & Services

Education services, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching; arranging and conducting educational seminars, conferences, symposiums, workshops and courses in the field of medicine; educational classes, courses, seminars and workshops and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease; educational classes, courses, seminars and workshops and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease provided electronically, on-line, the internet, and global communications networks; education services, namely, arranging and conducting of expert forums in the form of seminars, conferences, symposia, workshops and courses in the field of medicine; on-line medical training programs; providing non-downloadable on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease

Pharmaceutical preparations for the treatment and prevention of brain and central nervous system diseases and disorders; sanitary preparations for medical purposes; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated from or acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated from or acting on the brain; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, mood disorder, psychosis, stroke, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism, alcohol dependence and addiction; medical diagnostic preparations, substances, reagents and agents

Medical services in the field of psychiatry and psychology; medical advice in the field of medical and pharmaceutical preparations and substances; medical clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; medical treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; healthcare and medical services related to the treatment and prevention of central nervous system and brain disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; medical information services; providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues and medical management

Scientific and technological services, namely, research and design in the field of medicine; industrial analysis and research services in the field of pharmaceuticals; providing online non-downloadable software and an online searchable database in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention for the purpose of scientific research; providing a secured access website that gives medical experts the ability to upload, view, download, and share documents and images for the purposes of research and development in the field of clinical tests and trials, patient diagnostics, medicine, pharmaceuticals, medical disorders, diseases, treatment and prevention of disease; pharmaceutical research and development; scientific and technological services and research in the field of medical disorders, diseases and prevention of disease; scientific and technological services, namely, research in the field of the treatment and prevention of brain and central nervous system diseases, medical disorders and pharmaceuticals; medical research, conducting medical trials for others and testing of pharmaceuticals; conducting clinical research, trials and testing in the field of pharmaceuticals for others; medical diagnostic research and tests, including clinical trials for others; providing medical information in the field of pharmaceutical research and development, science, clinical tests and trials

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 20, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 20, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2017 EXRA
SOU EXTENSION 5 GRANTED
Dec 8, 2017 EX5G
SOU EXTENSION 5 FILED
Dec 5, 2017 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 5, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 22, 2017 EXRA
SOU EXTENSION 4 GRANTED
Jun 20, 2017 EX4G
SOU EXTENSION 4 FILED
Jun 20, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 20, 2017 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 20, 2017 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 5, 2017 EXRA
SOU EXTENSION 3 GRANTED
Jan 3, 2017 EX3G
SOU EXTENSION 3 FILED
Jan 3, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 3, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2016 EXRA
SOU EXTENSION 2 GRANTED
Jun 8, 2016 EX2G
SOU EXTENSION 2 FILED
Jun 1, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 1, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 3, 2016 EXRA
SOU EXTENSION 1 GRANTED
Feb 2, 2016 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 28, 2016 AITU
SOU EXTENSION 1 FILED
Dec 15, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 15, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 14, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 13, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 9, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 9, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 9, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 9, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2015 CRFA
ASSIGNED TO LIE
Mar 30, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 10, 2014 GNRN
NON-FINAL ACTION E-MAILED
Oct 10, 2014 GNRT
NON-FINAL ACTION WRITTEN
Oct 10, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2014 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 16, 2014 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2014 NWOS
NEW APPLICATION ENTERED
Sep 6, 2014 NWAP